Heatwurx (PCSA) Competitors $0.21 -0.01 (-2.72%) As of 03:28 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock PCSA vs. LSB, GLYC, GNPX, TLPH, DWTX, ADXN, AEON, APRE, KPRX, and IMNNShould you be buying Heatwurx stock or one of its competitors? The main competitors of Heatwurx include LakeShore Biopharma (LSB), GlycoMimetics (GLYC), Genprex (GNPX), Talphera (TLPH), Dogwood Therapeutics (DWTX), Addex Therapeutics (ADXN), AEON Biopharma (AEON), Aprea Therapeutics (APRE), Kiora Pharmaceuticals (KPRX), and Imunon (IMNN). These companies are all part of the "pharmaceutical products" industry. Heatwurx vs. Its Competitors LakeShore Biopharma GlycoMimetics Genprex Talphera Dogwood Therapeutics Addex Therapeutics AEON Biopharma Aprea Therapeutics Kiora Pharmaceuticals Imunon LakeShore Biopharma (NASDAQ:LSB) and Heatwurx (NASDAQ:PCSA) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, risk and dividends. Which has more risk and volatility, LSB or PCSA? LakeShore Biopharma has a beta of 0.58, suggesting that its share price is 42% less volatile than the S&P 500. Comparatively, Heatwurx has a beta of 1.3, suggesting that its share price is 30% more volatile than the S&P 500. Do insiders & institutionals hold more shares of LSB or PCSA? 52.6% of LakeShore Biopharma shares are held by institutional investors. Comparatively, 91.9% of Heatwurx shares are held by institutional investors. 9.6% of Heatwurx shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media prefer LSB or PCSA? In the previous week, LakeShore Biopharma and LakeShore Biopharma both had 1 articles in the media. Heatwurx's average media sentiment score of 1.89 beat LakeShore Biopharma's score of 1.25 indicating that Heatwurx is being referred to more favorably in the news media. Company Overall Sentiment LakeShore Biopharma Positive Heatwurx Very Positive Do analysts recommend LSB or PCSA? Heatwurx has a consensus price target of $2.00, suggesting a potential upside of 847.87%. Given Heatwurx's stronger consensus rating and higher probable upside, analysts plainly believe Heatwurx is more favorable than LakeShore Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LakeShore Biopharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Heatwurx 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is LSB or PCSA more profitable? LakeShore Biopharma's return on equity of 0.00% beat Heatwurx's return on equity.Company Net Margins Return on Equity Return on Assets LakeShore BiopharmaN/A N/A N/A Heatwurx N/A -319.56%-232.40% Which has preferable earnings and valuation, LSB or PCSA? Heatwurx has lower revenue, but higher earnings than LakeShore Biopharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLakeShore Biopharma$672.27M0.02-$61.09MN/AN/AHeatwurxN/AN/A-$11.85M-$3.08-0.07 SummaryHeatwurx beats LakeShore Biopharma on 8 of the 11 factors compared between the two stocks. Get Heatwurx News Delivered to You Automatically Sign up to receive the latest news and ratings for PCSA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PCSA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PCSA vs. The Competition Export to ExcelMetricHeatwurxMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.51M$2.44B$5.50B$9.40BDividend YieldN/A1.79%4.25%4.09%P/E Ratio-0.079.1928.1319.86Price / SalesN/A673.20424.9198.68Price / CashN/A160.6835.5357.53Price / Book0.464.728.235.71Net Income-$11.85M$30.99M$3.24B$257.80M7 Day Performance-8.22%0.96%0.66%1.12%1 Month Performance-18.85%10.05%8.07%11.30%1 Year Performance-87.66%-3.54%28.44%16.88% Heatwurx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PCSAHeatwurx3.1672 of 5 stars$0.21-2.7%$2.00+847.9%-87.6%$2.51MN/A-0.0720Positive NewsGap DownLSBLakeShore Biopharma0.9702 of 5 stars$1.11+2.8%N/A-76.6%$10.05M$80.82M0.00773Positive NewsGLYCGlycoMimetics0.5017 of 5 stars$0.16-6.6%N/A-99.5%$10.00M$10K-0.3450High Trading VolumeGNPXGenprex1.3456 of 5 stars$0.30+8.3%N/A-85.9%$9.95MN/A0.0020Positive NewsTLPHTalphera2.3742 of 5 stars$0.47-8.9%$5.00+955.1%-52.8%$9.72M$27K-1.0519Positive NewsHigh Trading VolumeDWTXDogwood Therapeutics1.8777 of 5 stars$5.08+6.7%$10.00+96.9%N/A$9.71MN/A-0.285ADXNAddex Therapeutics2.5265 of 5 stars$9.02+2.2%$30.00+232.4%+6.9%$9.57M$460K-26.5430Positive NewsAEONAEON Biopharma2.4206 of 5 stars$0.83-0.7%$360.00+43,039.6%-99.6%$9.43MN/A4.645APREAprea Therapeutics2.902 of 5 stars$1.70-1.7%$15.50+811.8%-58.4%$9.40M$1.50M-0.727Positive NewsKPRXKiora Pharmaceuticals3.1851 of 5 stars$3.08+2.7%$10.00+224.7%-26.6%$9.38MN/A-1.0610News CoverageIMNNImunon2.3042 of 5 stars$0.52-14.1%$15.50+2,880.8%-65.0%$9.12MN/A-0.3830 Related Companies and Tools Related Companies LakeShore Biopharma Alternatives GlycoMimetics Alternatives Genprex Alternatives Talphera Alternatives Dogwood Therapeutics Alternatives Addex Therapeutics Alternatives AEON Biopharma Alternatives Aprea Therapeutics Alternatives Kiora Pharmaceuticals Alternatives Imunon Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PCSA) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heatwurx Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heatwurx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
